Jagsonpal Pharmaceuticals Ltd

Jagsonpal Pharmaceuticals Ltd | Sector: Pharmaceuticals | ISIN: INE048B01027

₹ 296.00 (-0.42%)

29 Mar, 2023, 12:19:33 PM

Open
₹ 293.20

Prev. Close
₹ 297.25

Turnover(lac)
₹ 17.19

Day's High
₹ 298.45

Day's Low
₹ 293.20

52 Wk High
₹ 418.90

52 Wk Low
₹ 251.80

Book Value
₹ 55.02

Face Value
₹ 5.00

Mkt. Cap (Cr.)
₹ 775.46

P/E
33.90

EPS
8.78

Div. Yield
1.34

Corporate Actions

31 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

31 Jan , 2023

12:00 AM

Results

03 Nov , 2022

12:00 AM

Results

03 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

24 Aug , 2022

12:00 AM

AGM

Announcement date: 24 Aug , 2022

04 Aug , 2022

12:00 AM

Results

04 Aug , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

16 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

30 Jun , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

20 May , 2022

12:00 AM

EGM

22 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

22 May , 2022

12:00 AM

Results

04 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

20 May , 2022

12:00 AM

BookCloser

Jagsonpal Pharmaceuticals Ltd News and Update

Mamaearth puts IPO plan on hold: Reports

1 day ago |
4:08 PM

The valuation of the company was estimated to be up to $3 billion.

Adani Power sells Support Properties Private Ltd to AdaniConnex

IIFL News Service |
24 March, 2023 |
4:03 PM

Power Grid Corporation acquires Khavda II-C Transmission Ltd

23 March, 2023 |
4:02 PM

Hindustan Zinc's dividend payments may ease Vedanta's debt repayment challe...

IIFL News Service |
23 March, 2023 |
4:02 PM

FINANCIALS

No Data Available To Display Chart

Select Period:

Particulars ( Rupees In Crores.)	--	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

Particulars ( Rupees In Crores.)	--	--	--	--	--
Gross Sales	--	--	--	--
Excise Duty	--	--	--	--
Net Sales	--	--	--	--
Other Operating Income	--	--	--	--
Other Income	--	--	--	--
Total Income	--	--	--	--
Total Expenditure **	--	--	--	--
PBIDT	--	--	--	--
Interest	--	--	--	--
PBDT	--	--	--	--
Depreciation	--	--	--	--
Minority Interest Before NP	--	--	--	--
Tax	--	--	--	--
Deferred Tax	--	--	--	--
Reported Profit After Tax	--	--	--	--
Minority Interest After NP	--	--	--	--
Net Profit after Minority Interest	--	--	--	--
Extra-ordinary Items	--	--	--	--
Adjusted Profit After Extra-ordinary item	--	--	--	--
EPS (Unit Curr.)	--	--	--	--
Book Value (Unit Curr.)	--	--	--	--
Dividend (%)	--	--	--	--
Equity	--	--	--	--
Public Shareholding (Number)	--	--	--	--
Public Shareholding (%)	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--
PBIDTM(%)	--	--	--	--
PBDTM(%)	--	--	--	--
PATM(%)	--	--	--	--

No Record Found

PEER COMPARISON

Company Name	LTP (₹)	P/E (%)	Mkt.Cap (₹Cr.)	NP Qtr (₹Cr.)	Div.Yield (%)	Sales Qtr (₹.Cr)	Book Value (₹)
Sun Pharmaceuticals Industries Ltd	985.05	91.05	2,36,142.55	486.73	1.02	4,549.90	108.48
Dr Reddys Laboratories Ltd	4,526.10	31.95	75,408.91	324.60	0.66	3,879.60	1,156.21
Divis Laboratories Ltd	2,806.20	31.39	74,473.23	310.90	1.07	1,689.83	454.85
Cipla Ltd	886.00	25.95	71,800.08	678.52	0.56	3,541.16	291.76
Torrent Pharmaceuticals Ltd	1,537.45	49.81	52,239.05	229.00	1.56	1,826.00	191.38

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Jagsonpal Pharmaceuticals Ltd

Manish Gupta
Managing Director

Harsha Raghavan
Addtnl Non-Executive Director

Debasis Bikash Nandy
Independent Director

Radhika C Pereira
Addtnl Independent Director

Pallavi Dinodia
Addtnl Independent Director

Prithipal Singh Kochhar
Addtnl Non-Executive Director

Abhishek Joshi
Company Sec. & Compli. Officer

Summary

Summary Info Not Found

Reports by Jagsonpal Pharmaceuticals Ltd
Annual ReportAuditors Report
Management DiscussionDirectors Report

Reports by Jagsonpal Pharmaceuticals Ltd
Investor PresentationConference Call TranscriptConference Call Audio